Matches in SemOpenAlex for { <https://semopenalex.org/work/W4300962502> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W4300962502 abstract "Objectives: Bladder cancer (BLCA) is the most common malignant tumor in the urinary system, while the prognosis of muscle-invasive bladder cancer (MIBC) is poor. Cuproptosis might be a promising therapeutic approach to trigger tumor cell death. This study aimed to figure out the role of cuproptosis in BLCA and constructed a new cuproptosis scoring system to guide clinical diagnosis and individualize treatments. Methods: Consensus clustering was used to classify 490 patients with BLCA from TCGA and GEO cohorts. Survival outcomes and functional enrichment analyses were performed between the different subtypes. The cuproptosis scoring system was constructed by LASSO-Cox analysis. ESTIMATE, CIBERSORT, and ssGSEA were used to investigate the tumor microenvironment (TME). Drug sensitivity was evaluated with pRRophetic. An immunotherapy cohort was used to investigate the treatment response. The cuproptosis scoring system was verified in our own cohort with quantitative real-time PCR. Results: An overview of 12 cuproptosis genes (CuGs) in the TCGA database was depicted. Based on the mRNA expression profiles of CuGs, patients were classified into two cuproptosis molecular patterns. Based on the differential genes between the two cuproptosis patterns, the patients were classified into two cuproptosis gene clusters. There were distinct survival outcomes, signaling pathways, and TME between the two subtypes. A 7-gene cuproptosis scoring system was constructed. Patients with high cuproptosis scores showed worse OS and more immunosuppressing TME than those with low cuproptosis scores. The two cuproptosis score groups had distinct mutation profiles. Patients with high cuproptosis scores tended to be sensitive to chemotherapy drugs, but insensitive to immune checkpoint inhibitors (ICIs) treatment. Conclusion: This study depicted the landscape of cuproptosis in BLCA. We constructed a cuproptosis scoring system to predict the prognosis of BLCA patients. There were significant differences in survival outcomes, TME, mutation profiles, and drug sensitivities in high and low cuproptosis score patients. The cuproptosis scoring system could help oncologists comprehensively understand the tumor characteristic of BLCA and make individualized treatment strategies." @default.
- W4300962502 created "2022-10-04" @default.
- W4300962502 creator A5013038112 @default.
- W4300962502 creator A5055167423 @default.
- W4300962502 creator A5060613485 @default.
- W4300962502 creator A5065217157 @default.
- W4300962502 creator A5067565888 @default.
- W4300962502 creator A5085187792 @default.
- W4300962502 date "2022-10-03" @default.
- W4300962502 modified "2023-10-16" @default.
- W4300962502 title "Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis" @default.
- W4300962502 cites W1107917109 @default.
- W4300962502 cites W2075294566 @default.
- W4300962502 cites W2115462905 @default.
- W4300962502 cites W2130430382 @default.
- W4300962502 cites W2727910366 @default.
- W4300962502 cites W2763670669 @default.
- W4300962502 cites W2777192533 @default.
- W4300962502 cites W3023288864 @default.
- W4300962502 cites W3038244404 @default.
- W4300962502 cites W3048201207 @default.
- W4300962502 cites W3128646645 @default.
- W4300962502 cites W3203575974 @default.
- W4300962502 cites W3212348071 @default.
- W4300962502 cites W4206841660 @default.
- W4300962502 cites W4220817961 @default.
- W4300962502 cites W4221115671 @default.
- W4300962502 doi "https://doi.org/10.3389/fgene.2022.997573" @default.
- W4300962502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36263417" @default.
- W4300962502 hasPublicationYear "2022" @default.
- W4300962502 type Work @default.
- W4300962502 citedByCount "3" @default.
- W4300962502 countsByYear W43009625022022 @default.
- W4300962502 countsByYear W43009625022023 @default.
- W4300962502 crossrefType "journal-article" @default.
- W4300962502 hasAuthorship W4300962502A5013038112 @default.
- W4300962502 hasAuthorship W4300962502A5055167423 @default.
- W4300962502 hasAuthorship W4300962502A5060613485 @default.
- W4300962502 hasAuthorship W4300962502A5065217157 @default.
- W4300962502 hasAuthorship W4300962502A5067565888 @default.
- W4300962502 hasAuthorship W4300962502A5085187792 @default.
- W4300962502 hasBestOaLocation W43009625021 @default.
- W4300962502 hasConcept C104317684 @default.
- W4300962502 hasConcept C10515644 @default.
- W4300962502 hasConcept C121608353 @default.
- W4300962502 hasConcept C126322002 @default.
- W4300962502 hasConcept C143998085 @default.
- W4300962502 hasConcept C2776107976 @default.
- W4300962502 hasConcept C2777701055 @default.
- W4300962502 hasConcept C2780352672 @default.
- W4300962502 hasConcept C502942594 @default.
- W4300962502 hasConcept C50382708 @default.
- W4300962502 hasConcept C54355233 @default.
- W4300962502 hasConcept C60644358 @default.
- W4300962502 hasConcept C71924100 @default.
- W4300962502 hasConcept C72563966 @default.
- W4300962502 hasConcept C86803240 @default.
- W4300962502 hasConceptScore W4300962502C104317684 @default.
- W4300962502 hasConceptScore W4300962502C10515644 @default.
- W4300962502 hasConceptScore W4300962502C121608353 @default.
- W4300962502 hasConceptScore W4300962502C126322002 @default.
- W4300962502 hasConceptScore W4300962502C143998085 @default.
- W4300962502 hasConceptScore W4300962502C2776107976 @default.
- W4300962502 hasConceptScore W4300962502C2777701055 @default.
- W4300962502 hasConceptScore W4300962502C2780352672 @default.
- W4300962502 hasConceptScore W4300962502C502942594 @default.
- W4300962502 hasConceptScore W4300962502C50382708 @default.
- W4300962502 hasConceptScore W4300962502C54355233 @default.
- W4300962502 hasConceptScore W4300962502C60644358 @default.
- W4300962502 hasConceptScore W4300962502C71924100 @default.
- W4300962502 hasConceptScore W4300962502C72563966 @default.
- W4300962502 hasConceptScore W4300962502C86803240 @default.
- W4300962502 hasFunder F4320321885 @default.
- W4300962502 hasLocation W43009625021 @default.
- W4300962502 hasLocation W43009625022 @default.
- W4300962502 hasLocation W43009625023 @default.
- W4300962502 hasOpenAccess W4300962502 @default.
- W4300962502 hasPrimaryLocation W43009625021 @default.
- W4300962502 hasRelatedWork W1411054225 @default.
- W4300962502 hasRelatedWork W2178868239 @default.
- W4300962502 hasRelatedWork W2563663251 @default.
- W4300962502 hasRelatedWork W2771066073 @default.
- W4300962502 hasRelatedWork W2919897224 @default.
- W4300962502 hasRelatedWork W4206013364 @default.
- W4300962502 hasRelatedWork W4289517314 @default.
- W4300962502 hasRelatedWork W4294693701 @default.
- W4300962502 hasRelatedWork W4376226404 @default.
- W4300962502 hasRelatedWork W4381377675 @default.
- W4300962502 hasVolume "13" @default.
- W4300962502 isParatext "false" @default.
- W4300962502 isRetracted "false" @default.
- W4300962502 workType "article" @default.